Alzamend Neuro Inc
ALZN
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.19M
Close$
$0.21
88.3% downside
Current Fair Value
88.3% downsideOvervalued by 88.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.19 Million |
|---|---|
| Enterprise Value | $-400,485.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.63 |
| Beta | 0.19 |
| Outstanding Shares | 4,478,709 |
Return
| Return on Equity | -156.77% |
|---|---|
| Return on Assets | -106.49% |
| Return on Invested Capital | -157.16% |
Valuation & Multiples
| P/E Ratio | -0.82 |
|---|---|
| PEG | -6.85 |
| Price to Sales | - |
| Price to Book Ratio | 1.82 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.04 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 15, 2026
EPS Estimate
$-0.67
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 8, 2026
EPS Estimate
$-0.23
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 17.93%▲ 11.47% |
|---|---|
| Total Invested | $723,147▲ 61.71% |
| Investors Holding | 130% |
ESG Score
No data
About Alzamend Neuro Inc
3 employees